Spinifex Pharmaceuticals Raises US$45m in Series C Financing

Syndicate  includes  Novo  A/S  and  Canaan  Partners  alongside  existing investors New funds to drive the development of Spinifex’s lead candidate, EMA401, as a treatment for chronic pain Spinifex Pharmaceuticals, a pain drug development company, today announces it...